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Background: The aim was to study health-related quality of life, five years after an interven-
tion study among young adults with asthma.
Method: The design was a follow-up study of a cohort of young adults with asthma (nZ 64) and
248 general population controls. Both groups were investigated at follow-up with a respiratory
questionnaire and one generic quality-of-life instrument, and the asthma cohort also
completed one-asthma-specific questionnaire. The material was analyzed with multivariate
models.
Results: Female gender and low FEV 1 at baseline predicted both a decline during follow-up
and a low quality of life at follow-up. The asthma cohort and controls scored similarly
regarding generic quality of life. However, in the asthma cohort, females scored significantly
lower in the physical dimension of the generic instrument, especially in the domain of general
health.
Conclusions: There is an association between low FEV1 and a decline in quality of life among
young adults with asthma, i.e. low FEV1 predicts a decline in quality of life during a five-year
period. Young females with asthma seem to have lower quality of life compared with young
males with asthma.
ª 2009 Elsevier Ltd. All rights reserved.417824.
u.se (R. Sundberg).
9 Elsevier Ltd. All rights reserved.
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The goal of modern asthma treatment is to achieve and
maintain asthma control in a long-term perspective1 as such
control is beneficial not only to the management of clinical
manifestations but also to the improvement of health-
related quality of life (HRQL).2 We have, however, limited
knowledge of whether young adults with moderate to
severe childhood asthma have impaired quality of life or
how quality of life changes as young adults grow older.
There is a lack of studies of young adults: most of the
studies about quality of life are carried out in older or much
younger populations. In one review it was concluded that
the conventional clinical parameters of lung function,
symptoms, and reliever medication use predict the levels of
quality of life differently depending on the level of asthma
severity under study. Furthermore, these traditional
measures of asthma severity and asthma control explain
only half of the variance of HROL.3 There are data which
suggest that personality can influence how asthma patients
adhere to asthma medication treatment, and report their
control and HRQL.4
We have previously assessed the effectiveness of
a limited asthma education program with the aim of
improving asthma control and quality of life in a group
of young adults with asthma.5 We have now, five years later,
performed a questionnaire-based follow-up in all 97 subjects
and added a randomly selected group of controls from the
general population. The aims of the study were to analyze
whether quality of life has changed during follow-up and,
whether young adults with asthma have impaired quality of
life compared with a control group at the same age.Material and methods
Study population
Between 1997 and 1998, 97 consecutive patients between the
ages of 18 and 25 who were referred to the special ‘‘Asthma
outpatient clinic for young adults’’ from the Children’s
Hospital at the Sahlgrenska University Hospital in Go¨teborg
participated in a one-year computerized limited asthma
education program.5 The present study population comprised
these 97 subjects with asthma (the asthma cohort) and 500
randomly selected controls from the same source population
in the same age interval. The controls were selected from the
general population at the year of the follow-up, i.e. 2003. The
Ethics Committee at the Faculty of Medicine, University of
Gothenburg approved the study.
Methods
The study consisted of a postal self-administered ques-
tionnaire. Non-responders received two reminders. The
questionnaire consisted of two parts. One part was devel-
oped from previous questionnaires6e10 and included items
about asthma, rhinitis and eczema, use of medication,
smoking, professional experience, physical activity, and
family history of asthma and allergy. The second part
consisted of two quality of life questionnaires, one genericand one asthma-specific. The asthma-specific questionnaire
was sent only to the asthma cohort.
The generic questionnaire was the Short Form 36 Health
Survey (SF-36),which consists of 36 items,which refer toeight
health scales related to daily life activities.11 Four of these
health scales represent the physical dimension: (1) physical
functioning, (2) role-functioning-physical, (3) bodily pain and
(4) general health: the remaining four scales represent
the mental dimension: (5) vitality, (6) social functioning,
(7) role-functioning-emotional; and (8) mental health. All of
these health scales score on a range from 0 to 100, with 100
representing the highest level of functioning and well being.
The SF-36 questionnaire was used at follow-up only.
The asthma-specific questionnaire was the Living with
Asthma Questionnaire,12e14 which includes 11 domains:
(1) social and leisure activities, (2) sports, (3) holidays,
(4) sleep, (5)workandother activities, (6) colds, (7)mobility,
(8) effects on others, (9) medication usage, (10) sex and
(11) dysphoric states and attitudes. The subjects responded
to the questionnaire on a three-point scale: untrue, slightly
true and very true. The alternative response ‘‘not appli-
cable’’ was also available. Quality of life was calculated
according to Hyland as the sum of the points in each item
divided by the sum of the points in each area, i.e. the mean
scores are calculated and analyzed as continuous variables.
This questionnaire was completed both at the start of the
study and at follow-up.Definitions
The following terms used in analysis and discussion were
defined as positive responses to the respective yes/no
questions and refined as indicated by the accompanying
comments.
Physician-diagnosed asthma: ‘‘Have you been diagnosed
by a physician as having asthma?’’
Prescribed asthma medication: ‘‘Have you used any
asthma medication during the last 12 months?’’ If the
answer was ‘‘yes’’, the following questions were asked:
‘‘Have you used rapid-acting inhaled beta2- agonist?’’
and ‘‘Have you used inhaled corticosteroids?’’
Current asthma: affirmative answer to the question,
‘‘Have you been diagnosed by a physician as having
asthma?’’ and either ‘‘Have you had asthma symptoms
during the last 12 months?’’, or ‘‘Have you used asthma
medication during the last 12 months?’’
Body mass index was calculated by weight (kg) divided
by the square of the height (m2) and it was classified by
the current WHO classification.
Smoking: subjects were classified as either never
smoked or ex-smoker/smoker.
Physical exercise was classified in four categories often,
sometimes, seldom or never. The question was ‘‘How
often do you exercise until breathlessness or until you
are dripping with perspiration in your spare time’’.
A sample of non-respondents from the asthma cohort
(nZ 32) and from the control group (nZ 114) was
randomly chosen for a telephone interview based on the
short questionnaire. Of these, 70 could be reached for the
1582 R. Sundberg et al.interview, 19 from the asthma cohort and 51 from the
control group.
Statistical analyses
For the analyses the statistical package SAS, version 8 was
used. We used chi square test in the univariate analyses of
differences regarding characteristics Student t-test for
continuous variables, p-values< 0.05 were considered
significant.
In the multivariate analyses generalized linear multiple
regression models (PROC GLM) were used to estimate the
associations between dependent and independent vari-
ables. We analyzed the change in quality of life in the
asthma cohort as the difference in total sum in the Hyland
questionnaire between year 1 and follow-up (year 6).
Further, at follow-up we analyzed the predictors for total
overall scores in the asthma-specific questionnaire and the
predictors for the physical and mental dimensions of the
generic questionnaire (SF-36). In all models the indepen-
dent variables included gender, smoking, and educational
level. In addition, skin-prick test, lung function at baseline,
and current asthma at follow-up were added to some
models. When we analyzed change during follow-up the
baseline value was also included in the model.
Results
Descriptive results
At follow-up, 66% (nZ 64/97) of the asthma cohort and 50%
(nZ 248/500) of the control group answered the ques-
tionnaire: demographics are shown in Table 1. The preva-
lence of ever having smoked was higher in the asthma
cohort than in the control group (54.7% vs 31.9%). There
were no significant gender differences regarding different
asthma symptoms in either the cohort or the control group
(data not shown).
In the asthma cohort 82.8% (nZ 53) affirmed and 17.2%
(nZ 11) denied ever regularly using any asthma medica-
tion, all 11 ‘‘deniers’’ were female. The use of inhaled
steroids only was reported by 65.6%.Table 1 Study population, young adults with asthma (nZ 64) a
Asthma cohort
All, nZ 64 Males, nZ 28 Fema
Age (yr) 26.3 (0.3) 26.1 (0.3) 26.5
BMI (kg/m2) 23.5 (SEZ 0.4) 24.3 (SEZ 0.6) 22.9
Asthma hereditary 25.0% (nZ 16) 32.0% (nZ 9)a 19.4%
Positive skin-prick
test at baseline
87.5% (nZ 56) 96.4% (nZ 27) 80.5%
Ex-smoker/smoker 54.7% (nZ 35) 28.6% (nZ 8) 47.2%
Education level e university 54.7% (nZ 35) 64.3% (nZ 18) 50.0%
Physical exercise e often 48.4% (nZ 31) 64.3% (nZ 18) 36.1%
Current asthma 87.5% (nZ 56) 89.2% (nZ 25) 86.1%
n.a.Z Not applicable.
a Males with astma heriditary in the asthma cohort compared to thHealth-related quality of life
The overall score at follow-up of quality of life in the
asthma cohort assessed with the ‘‘Living with Asthma
Questionnaire’’ was 162.3 (SEZ 3.7). Multiple linear
regression modeling analysis showed that female gender
(pZ 0.01) and a low FEV1 at baseline (pZ 0.002) predicted
a lower quality of life at follow-up. We also analyzed the
change in quality of life in the asthma cohort. Quality of life
assessed with the specific instrument ‘‘Living with asthma’’
did not change significantly during the five years of follow-
up (e3.32 [SEZ 3.8] with slight differences between males
[e2.8] and females [e3.8]). Despite the univariate results,
in a multiple linear regression analysis female gender
(pZ 0.04) and low FEV1 (pZ 0.01) at baseline predicted
a decline in quality of life in the asthma cohort.
However, in certain domains there were significantly
declines of the scored quality of life outcomes. In the
domain of holidays there was a significant decline for the
whole group (e0.44, SEZ 0.06, p< 0.0001), which was
most marked in males (e0.51, SEZ 0.09, p< 0.0001) as
compared with females (e0.39, SEZ 0.08, p< 0.0001).
In the univariate analysis of the generic instrument
(SF-36) the asthma cohort scored significantly lower
compared to the general population controls regarding the
physical dimension (52.7 vs 54.0, pZ 004), especially in
physical functioning (PF) (pZ 0.004) and general health
(GH) (pZ 0.0001) (Table 2). However, regarding the mental
dimension there was an indication of higher scoring for the
asthma cohort (47.2 vs 44.8, pZ 0.18). This was especially
seen in social functioning (SF) (pZ 0.04) and role-func-
tioning-emotional (RE) (pZ 0.01). In the multiple regres-
sion models there were no significant differences between
the asthma cohort and the controls in either the physical
dimension or the mental dimension. The model was
adjusted for gender, education and smoking habits.
Within the asthma cohort females, scored lower in the
physical dimension than males (pZ 0.0009): this was most
obvious in the domain of general health (pZ 0.0002). In the
control group, females scored lower in the mental dimen-
sion than males (pZ 0.002), which was most obvious in the
domain of role-functioning-emotional (RE) (pZ 0.0009)
(Table 2). We observed similar results in the multiplend control group (nZ 248) at the same age.
Control group
les, nZ 36 All, nZ 248 Males, nZ 110 Females, nZ 138
(0.3) 25.7 (0.1) 25.7 (0.1) 25.6 (0.1)
(SEZ 0.5) 23.1 (SEZ 0.2) 24.0 (SEZ 0.3) 22.4 (SEZ 0.2)
(nZ 7) 13.7% (nZ 34) 11.8% (nZ 13) 15.2% (nZ 21)
(nZ 29) n.a. n.a. n.a.
(nZ 17) 31.9% (nZ 79) 26.4% (nZ 29) 36.2% (nZ 50)
(nZ 17) 55.2% (nZ 137) 53.6% (nZ 59) 57.4% (nZ 78)
(nZ 13) 54.8% (nZ 136) 58.2% (nZ 64) 52.2% (nZ 72)
(nZ 31) 5.2% (nZ 13) 2.7% (nZ 3) 7.2% (nZ 10)
e control group (pZ 0.007).
Table 2 SF-36 scores in the whole asthma cohort and in the whole control group. Comparison of SF-36 scores between males
and females in the asthma cohort and in the control group.
SF-36 health scales Asthma cohort Control group
All
(nZ 64)
Males
(nZ 28)
Females
(nZ 36)
p-Value All
(nZ 248)
Males
(nZ 110)
Females
(nZ 138)
p-value
Physical dimension 52.7 (0.9) 55.8 (0.8) 50.2 (1.3) 0.0009 54.0 (0.5) 54.1 (0.6) 53.9 (0.7) 0.29
Physical functioning (PF) 93.7 (1.2) 97.6 (0.7) 90.6 (2.0) 0.003 93.4 (1.1) 94.1 (1.7) 92.8 (1.3) 0.02
Role-functioning-physical (RP) 90.5 (3.1) 94.6 (3.9) 87.1 (4.6) 0.04 85.8 (1.8) 85.7 (2.8) 85.9 (2.4) 0.46
Bodily pain (BP) 85.1 (2.4) 91.5 (2.8) 80.0 (3.5) 0.01 81.6 (1.4) 84.9 (1.8) 79.1 (2.1) 0.07
General health (GH) 65.7 (2.9) 77.9 (3.6) 55.9 (3.7) 0.0002 78.2 (1.1) 80.3 (1.6) 76.5 (1.5) 0.05
Mental dimension 47.2 (1.2) 47.5 (1.7) 47.0 (1.6) 0.38 44.8 (0.7) 47.5 (0.9) 42.7 (1.1) 0.002
Vitality (VT) 62.5 (2.6) 67.4 (3.6) 58.7 (3.6) 0.07 61.7 (1.3) 66.0 (1.8) 58.3 (1.8) 0.00
Social functioning (SF) 86.7 (2.6) 91.5 (3.0) 82.9 (3.9) 0.08 82.1 (1.5) 86.7 (1.8) 78.4 (2.3) 0.004
Role-functioning-emotional (RE) 89.4 (3.3) 90.1 (4.6) 88.9 (4.7) 0.39 80.2 (2.2) 87.6 (2.7) 74.4 (3.2) 0.0009
Mental health (MH) 75.0 (2.2) 76.3 (3.0) 73.9 (3.1) 0.36 74.0 (1.2) 77.3 (1.6) 71.3 (1.6) 0.009
Standard error (SE) within parentheses.
p-ValueZ differences between males and females in the asthma cohort and in the control group.
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significantly associated with low scoring on the physical
dimension of SF-36 in a model adjusted for current asthma,
smoking, and education. This was not seen for the mental
dimension. In the control group, female sex was signifi-
cantly associated with low scoring on the mental dimension
of SF-36. This was not seen for the physical dimension.
Non-responders
Non-respondents to the broader study (asthma cohort and
controls), who subsequently answered the short telephone
survey, gave no different results for ever having had
asthma, asthma symptoms or asthma medication than did
respondents from the study groups. There were a few more
subjects with wheezing among the respondents in the
control group 14.1% vs 3.9% of non-respondents in the
control group.
Discussion
The most important result from the present study of young
adults with asthma is that females seem to a have
decreased asthma-related quality of life compared to
males, which also is seen in their generic quality of life,
where asthmatic females scores lower in the physical
dimension.
The study design has some important limitations. The
most important is low power; our asthma cohort consisted
of 64 subjects and 248 controls, which mainly limits the
ability to study categorical variables. Further, the control
group was not studied longitudinally, which makes it
impossible to study the change of generic quality of life in
a prospective manner.
We found that that the overall score of quality of life in
the asthma cohort assessed with the Living with Asthma
Questionnaire, decreased at five-year follow-up in females.
Further, we found that low FEV1 at baseline also predicted
decline in asthma-related quality of life. We did not,however, find that persistent asthma symptoms predicted
lower quality of life scores as others have described.15
Effect size, the ratio of the mean change in the score to the
SD of the baseline score was 0.13 in the present study.16
The largest sector of decline in asthma-related quality
of life was in the domain of holidays (pZ 0.0001). This
corresponds fairly well to the results of a European survey
about the limitations of severe asthma: 28% (nZ 1300)
reported, holidays, as an activity affected by asthma.
Severe asthma has a major impact on patients e restricting
their activities, causing embarrassment, imparting feare
and is a burden on healthcare systems.17 One explanation
could be that the asthma patients associate holidays with
‘‘physical activity’’, ‘‘pets’’, ‘‘going out with friends’’,
‘‘holidays’’ activity e known to have impact on their lives.
Their multiple regression analysis also showed a statisti-
cally significant association between the differences in
overall scores between year 6 and year 1. Female gender
(pZ 0.04) and low FEV1 at baseline (pZ 0.01) were asso-
ciated with low asthma-related quality of life.
SF-36 is a generic, well-validated and reliable instru-
ment for the measurement of health-related quality of life
in adults and adolescents from the age of 14, and normative
data are available for the Swedish population.11 The results
of SF-36 in the present study did not show any significant
difference between the asthma cohort and the control
group in the multiple linear regression models, even if
there were slight differences in the univariate analyses.
There was a gender difference, with, females scoring lower
in the physical dimension compared to men most markedly
in the domains of physical functioning and general health.
General opinion is that, an effect size of 5 points in SF-36
(0e100 scale), represent a clinical significance.18 We have
gender differences in that magnitude regarding physical
dimension in the asthma cohort. Statistically significant
associations between gender and physical dimensions of
SF-36 were also seen in a multiple linear regression
adjusted for current asthma, smoking, and university level
education (pZ 0.0003). This accords with other studies,
Lee et al. reported that female asthma patients reported
1584 R. Sundberg et al.significantly greater healthcare utilization, more unsched-
uled office contact, more asthma control problems, and
lower asthma-related quality of life.19 We have also iden-
tified one recently published study showing that among
subjects with asthma, disease-specific quality of life is most
associated with perceived stress and disease severity.20 In
the present study was the mental dimension of quality of
life not worse in asthmatics than in controls. Ten Brinke
et al. have shown in a study of severe asthma, aged 18e75
year, that the morbidity and costs of asthma might be
related to the level of psychological dysfunction rather
than to asthma severity.21
In the control group there was significant difference in
the mental dimension in females compared to men and this
was found in all four domains: vitality, social functioning,
role-functioning-emotional, and mental health. The
multiple linear regression model adjusted for smoking and
university level education showed a statistically significant
association between gender and mental dimension. There
was also a clinical significance. We have no explanation for
this observation.
Low adherence is associated with use of inhaled
steroids22: at baseline (year 1) 97% of the asthma cohort
used inhaled steroids5 and in the follow-up only 66%
(nZ 42/64) reported use of inhaled steroids. However,
astonishing 11 of 36 women answered that they never had
used medication for their asthma, this could contribute to
the lower HRQL. Elsewhere, non-adherence to inhaled
steroids has been ascribed to various causes including the
facts that asthma is a chronic illness requiring prolonged
treatment, that the prescribed medications are used as
prophylactics, and that the consequences of cessation of
treatment are delayed.23
Osborne et al. suggest that men and women respond
differently to their asthma, and observed gender differ-
ences in various measures of asthma such as hospital
admissions, quality of life and use of metered dose
inhalers, may be related to this difference in response to
disease, rather than to real differences such in the disease
between men and women.24Conclusion
There is an association between low FEV1 and a decline in
quality of life among young adults with asthma, i.e. low
FEV1 predicts a decline in quality of life during a five-year
period. Young females with asthma seem to have lower
quality of life compared with young males with asthma.Acknowledgements
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